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ABSTRACT
Background and Objectives: The pathogenesis of hyponatremia (serum sodium <135 mEq/L) in Kawasaki disease (KD) 
remains unclear. We investigated the clinical significance of hyponatremia, and the role of interleukin (IL)-6 and IL-1β in the 
development of hyponatremia and syndrome of inappropriate antidiuretic hormone secretion (SIADH) in KD. Subjects and 
Methods: Fifty KD patients were prospectively enrolled and analyzed for clinical and laboratory variables according to the 
presence of hyponatremia or SIADH. Results: Thirteen KD patients (26%) had hyponatremia and 6 of these had SIADH. 
In patients with hyponatremia, the percentage of neutrophils (% neutrophils), C-reactive protein (CRP), and N-terminal pro-
brain natriuretic peptide (NT-proBNP) were higher than in those without hyponatremia, while serum triiodothyronine (T3) 
and albumin were lower. Patients with hyponatremia had a higher incidence of intravenous immunoglobulin-resistance but 
this was not statistically significant. No differences existed between patients with and without SIADH with regard to clinical 
or laboratory variables and the incidence of IVIG-resistance. Serum sodium inversely correlated with % neutrophils, CRP, 
and NT-proBNP, and positively correlated with T3 and albumin. Serum IL-6 and IL-1β levels increased in KD patients and 
were higher in patients with hyponatremia. Plasma antidiuretic hormone increased in patients with SIADH, which tended 
to positively correlate with IL-6 and IL-1β levels. Conclusion: Hyponatremia occurs in KD patients with severe inflammation, 
while increased IL-6 and IL-1β may activate ADH secretion, leading to SIADH and hyponatremia in KD. (Korean Circ J 
2010;40:507-513)
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Introduction
Hyponatremia in Kawasaki disease (KD) was first report-
ed in 1982,
1) with occasional reports since then of KD associ-
ated hyponatremia and syndrome of inappropriate antidiuretic 
hormone secretion (SIADH).
2-4) Multiple etiologies for hypo-
natremia in KD have been suggested
1) and cerebral vasculitis 
has been thought to be related to SIADH.
3) However, the pre-
cise pathogenesis of hyponatremia in KD has yet to be con-
clusively determined. Recently, it was revealed that many in-
flammatory cytokines such as interleukin (IL)-6 and IL-1β are 
elevated during the acute phase of KD,
5-8) and a relationship 
between these cytokines and antidiuretic hormone (ADH) se-
cretion has been suggested.
9)10) It has therefore been speculat-
ed that these cytokines may be involved in the pathogenesis 
of hyponatremia due to SIADH in KD. 
In this study, we investigated the clinical significance of hy-
ponatremia in the acute phase of KD, and the role of IL-6 and 
IL-1β in the development of hyponatremia and SIADH asso-
ciated with KD. 
Subjects and Methods
During the study period from November 2008 to July 2009, 
54 children who met the diagnostic criteria for KD
11) were 
prospectively enrolled and treated with intravenous immuno-
globulin (IVIG), 2 g/kg and aspirin 80-100 mg/kg/day at the 
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dong Hospital. Four of the 54 KD patients were excluded who 
had clinical signs of dehydration at the time of admission as 
they did not match the diagnostic criteria for SIADH. Thus, 
50 KD patients (28 boys, 22 girls; mean age 29.0±23.7 months; 
range 3-89 months) were studied in this study. Thirty-five age- 
and sex-matched healthy children without fever served as the 
control group. 
In KD patients, we measured complete blood cell count, 
serum sodium (Na) and osmolality, urine Na and osmolality, 
aspartate aminotransferase, alanine aminotransferase, albu-
min, C-reactive protein (CRP), N-terminal pro-brain natriure-
tic peptide (NT-proBNP), and triiodothyronine (T3) in the 
acute (2 to 9 days after the onset of disease; mean, 4.3±1.7 days) 
and subacute phase (3 to 9 days after IVIG infusion; mean, 5.9 
±2.6 days) of KD.
We divided the KD patients into hyponatremic and non-hy-
ponatremic groups and divided hyponatremic KD patients 
into SIADH and non-SIADH groups. Between each group, we 
compared the clinical variables (age, gender, duration of fe-
ver at initial IVIG infusion, and the presence of diarrhea on 
admission), laboratory variables, the incidences of IVIG-resis-
tance and coronary artery lesions (CALs).
Blood samples for determination of serum IL-6 and IL-1β 
levels were obtained from KD patients in the acute phase of 
the illness (before IVIG infusion) and from healthy controls, 
which were stored at -70°C until measurement. Serum levels 
of IL-6 and IL-1β were measured by enzyme-linked immu-
nosorbent assay (ELISA) using V-MAX 220 VAC ELISA read-
er (Molecular Devices, Sunnyvale, CA, USA), and the rela-
tionship between these cytokines and serum Na concentr-
ations was investigated. Plasma ADH levels were measured 
in KD patients with hyponatremia by radioimmunoassay us-
ing Cobra II Gamma-counter (Hewlett-Packard, Meriden, CT, 
USA), and the relationship with cytokines was also investi-
gated. This study was approved by the Institutional Review 
Board of Ewha Womans University Mokdong Hospital (#216-
2) and written informed consents were obtained from the pa-
rents of each patient.
Definition
Hyponatremia was defined as a serum Na level <135 mEq/
L and SIADH was defined as follows: 1) hyponatremia (serum 
Na <135 mEq/L), 2) hypotonicity (plasma osmolality <280 
mOsm/kg), 3) inappropriately concentrated urine (>100 mOsm/ 
kg), 4) an elevated urine Na concentration (>20 mEq/L), 5) nor-
mal renal, adrenal, and thyroid function, and 6) absence of hy-
povolemia or dehydration.
12) 
Duration of fever was defined as the time elapsed from the 
onset of disease to the start of initial IVIG infusion. As an ex-
clusion criterion, dehydration was defined as weight loss >3% 
and/or the presence of clinical findings such as dry mucous 
membrane, decreased skin turgor, sunken anterior fontanel, 
or hemoconcentration (hematocrit >50%).
13) 
IVIG-resistance was defined when additional rescue ther-
apies were required owing to persistent or recrudescent fe-
ver (≥38.0°C or 100.4°F) at least 48 hours after the end of ini-
tial IVIG infusion. CALs were assessed by echocardiography 
and were defined by either an internal diameter of the coro-
nary artery lumen >3 mm in a child <5 years or >4 mm in a 
child ≥5 years, the internal diameter of a segment being at 
least 1.5-times as large as that of an adjacent segment or when 
the lumen was clearly irregular.
14)
Statistical analysis
All data were analyzed with Statistical Package for the Social 
Sciences (SPSS) for Windows software version 12.0 (SPSS Inc, 
Chicago, IL, USA). Descriptive statistics are presented as 
mean±standard deviation for continuous variables or as the 
number (percentage) of patients for categorical variables. 
Mann-Whitney test and Fisher’s exact test were used for com-
paring variables between two independent groups. Wilcoxon 
signed rank test was used for comparing variables between 
pre- and post-IVIG infusion. Pearson’s correlation and Spear-
man’s correlation were used for correlations between each vari-
able. A level of p<0.05 was considered as statistically significant.
Results
Incidences of hyponatremia and syndrome 
of inappropriate antidiuretic hormone secretion 
in Kawasaki disease
Thirteen (26%) of 50 KD patients had hyponatremia be-
fore IVIG infusion. Six (46%) of the 13 KD patients with hy-
ponatremia had SIADH. One of the 6 KD patients with SI-
ADH had aseptic meningitis. Serum Na concentrations ranged 
from 125 to 134 mEq/L with a mean of 132.1±2.3 mEq/L be-
fore IVIG infusion, and increased to within the normal range 
after IVIG infusion (range, 135 to 138 mEq/L; mean, 136.4± 
Fig. 1. Changes in serum sodium (Na) level in 13 Kawasaki disease 
patients with hyponatremia (serum Na <135 mEq/L) before and af-
ter intravenous immunoglobulin (IVIG) infusion.
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1.2 mEq/L, p=0.001) in all patients except one male patient 
whose serum Na was 134 mEq/L (post-IVIG infusion). He 
exhibited a serum Na of 125 mEq/L (pre-IVIG infusion), which 
was the lowest concentration in the study (Fig. 1). 
After IVIG infusion, hyponatremia newly occurred in 8 
KD patients including 1 KD patient with SIADH. There 
were no KD patients who had developed hyponatremia be-
fore IVIG infusion. Serum Na concentrations ranged from 
132 to 134 mEq/L (mean, 133.4±0.9 mEq/L). Four of the 8 
KD patients had excessive administration of hypotonic main-
tenance fluid (135% to 150% of maintenance requirements 
proposed by Holliday and Segar
15)) during the management 
of accompanying rotaviral gastroenteritis (n=2), urinary tract 
infection (n=1), and hepatitis (n=1), leading to dilutional hy-
ponatremia. 
We clarify that we were concerned about hyponatremia at 
the time of presentation, not that which developed after IVIG 
treatment. Therefore, all the reported results relate to hypo-
natremia at presentation.
Comparision between Kawasaki disease patients 
with and without hyponatremia 
Between KD patients with (n=13) and without hyponatre-
mia (n=37), there was no difference in clinical variables in-
cluding age, gender, and duration of fever at initial IVIG infu-
sion, and the presence of diarrhea. Regarding laboratory vari-
ables, percentage of neutrophils in white blood cells (% neu-
trophils), CRP, and NT-proBNP were higher, and serum T3 
and albumin were lower in KD patients with hyponatremia 
than in those without hyponatremia. 
The KD patients with hyponatremia had a higher incidence 
of IVIG-resistance but this was not statistically significant (p= 
0.065). There was no difference in the incidence of CALs be-
tween the two groups (Table 1). 
Comparision between hyponatremic Kawasaki 
disease patients with and without syndrome
of inappropriate antidiuretic hormone secretion 
Between hyponatremic patients with (n=6) and without 
SIADH (n=7), no differences existed in clinical variables (age, 
gender, duration of fever at initial IVIG infusion, and the pres-
ence of diarrhea), laboratory variables, and the incidence of 
IVIG-resistance (Table 2).
 
Correlation between serum Na and laboratory 
variables 
In 50 KD patients, serum Na inversely correlated with % neu-
trophils (r=-0.51, p=0.000) (not shown), CRP (r=-0.41, p=0.004) 
(Fig. 2A) and NT-proBNP (r=-0.47, p=0.001) (Fig. 2B). In con-
trast, serum Na had positive correlations with T3 (r=0.34, 
p=0.021) (Fig. 2C) and albumin (r=0.35, p=0.014) (not shown).
Table 1. Clinical and laboratory variables in Kawasaki disease pa-
tients with and without hyponatremia
Variables
Patients with
hyponatremia
(n=13)
Patients without 
hyponatremia
(n=37)
p
Age (month) 035.2±23.9 026.8±21.2 0.268
Male gender, n (%) 9 (69.2) 19 (51.4) 0.339
Duration of fever (day) 03.6±1.3 04.5±1.7 0.087
Diarrhea, n (%) 2 (15.4) 0 (0) N/A
Serum sodium (mEq/L)  32.1±2.3 137.4±1.50 0.000
WBC (×10
3/mm
3) 13.4±6.5 13.1±4.2 0.732
% neutrophils (%) 074.0±16.2 056.7±14.0 0.000
Platelet (×10
3/ mm
3) 315.4±86.2 337.3±90.6 0.472
AST (IU/L) 0193±502 0  99±197 0.132
ALT (IU/L) 0117±262 0098±223 0.195
CRP (mg/dL) 10.9±7.1   6.7±5.3 0.043
NT-proBNP (pg/mL) 01824±2603 00793±1321 0.013
T3 (ng/dL) 095.6±31.8 125.0±36.3 0.021
Albumin (g/dL) 03.6±0.2 03.9±0.3 0.026
IVIG-resistance, n (%) 4 (30.8) 3 (8.1) 0.065
CAL, n (%) 1 (7.7)0 3 (8.1) 1.000
N/A: not applicable, WBC: white blood cell, AST: aspartate amino-
transferase, ALT: alanine aminotransferase, CRP: C-reactive pro-
tein, NT-proBNP: N-terminal pro-brain natriuretic peptide, T3: tri-
iodothyronine, IVIG: intravenous immunoglobulin, CAL: coronary 
artery lesion
Table 2. Clinical and laboratory variables in hyponatremic Kawa-
saki disease patients with and without SIADH
Variables
Patients with 
SIADH
(n=6)
Patients without
SIADH 
(n=7)
p
Age (month) 034.0±24.2 036.2±25.6 0.945
Male gender, n (%) 3 (50)0. 6 (85.7) 0.266
Duration of fever (day) 03.7±1.2 ..3.6±1.2 0.101
Diarrhea, n (%) 1 (16.7) 1 (14.3) 1.000
Serum sodium (mEq/L) 132.8±0.90 131.5±3.10 0.534
WBC (×10
3/mm
3) 14.2±6.5 12.8±6.9 0.628
% neutrophils (%) 79.3±7.9 . 69.5±20.5 0.181
Platelet (×10
3/ mm
3) 344.3±94.4 290.7±76.7 0.445
AST (IU/L) 150±25 ..216±582 0.366
ALT (IU/L) 103±57 ..122±257 0.628
CRP (mg/dL) 13.1±7.0 ..8.9±7.2 0.181
NT-proBNP (pg/mL) 01342±1922 ..2305±3264 0.394
T3 (ng/dL) 093.9±25.1 ..97.1±38.8 0.792
Albumin (g/dL) 03.6±0.3 ..3.7±0.2 0.818
IVIG-resistance, n (%) 1 (16.7) 3 (42.9) 0.559
CAL, n (%) 0 (0)00 1 (14.3) N/A
SIADH: syndrome of inappropriate antidiuretic hormone secre-
tion, WBC: white blood cell, AST: aspartate aminotransferase, ALT: 
alanine aminotransferase, CRP: C-reactive protein, NT-proBNP: N-
terminal pro-brain natriuretic peptide, T3: triiodothyronine, IVIG: 
intravenous immunoglobulin, CAL: coronary artery lesion, N/A: 
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Relation of intravenous immunoglobulin-resistance
and coronary artery lesions to hyponatremia
Of the 50 KD patients, there were 7 patients with IVIG-
resistance: 5 patients were treated with additional IVIG (2 g/
kg) and 2 patients with both IVIG and methylprednisolone 
pulse therapy. The KD patients with IVIG-resistance had a 
lower Na concentration (134.4±2.9 mEq/L vs. 136.3±2.8 mEq/ 
L, p=0.065) and a higher incidence of hyponatremia {4/7 
(57.1%) vs. 9/43 (20.9%), p=0.083} than those without IVIG-
resistance, but with no statistical significance. 
As for coronary complications, there were 4 patients with 
CALs, all of which were <5 mm in diameter. Between KD pa-
tients with and without CALs, there were no significant dif-
ferences in serum Na levels (135.7±3.7 mEq/L vs. 136.1±2.9 
mEq/L, p=1.000) and the incidence of hyponatremia {1/4 (25%) 
vs. 12/46 (26%), p=0.769}.
Comparison in interleukin-6 and interleukin-1β 
between groups 
Serum IL-6 and IL-1β levels were measured in 42 KD pa-
tients and 35 healthy controls. There were no differences be-
tween the KD patients and the control group in regard to age 
(29.0±22.0 months vs. 20.6±18.4 months, p=0.062) and gen-
der {male/female, 25/17 vs. 20/15, p=1.000}. However, serum 
levels of IL-6 and IL-1β were higher in KD patients than in 
healthy controls (IL-6, 89.6±74.2 pg/mL vs. 16.6±44.8 pg/
mL, p=0.000; IL-1β, 45.0±71.0 pg/mL vs. 14.0±13.8 pg/mL, 
p=0.021) (Fig. 3A). 
In the 42 KD patients, 11 patients with hyponatrema had 
higher levels of IL-6 and IL-1β than 31 patients without hy-
ponatremia (IL-6, 184.3±77.8 pg/mL vs. 70.7±58.4 pg/mL, 
p=0.002; IL-1β, 104.6±143.7 pg/mL vs. 31.4±35.6 pg/mL, 
p=0.129) (Fig. 3B) 
In the 11 KD patients with hyponatremia, serum IL-6 and 
IL-1β levels were higher in 5 KD patients with SIADH than 
in 6 patients without hyponatremia (IL-6, 210.0±88.6 pg/mL 
vs. 145.7±59.8 pg/mL, p=0.400; IL-1β, 150.6±182.2 pg/mL 
vs. 35.7±19.6 pg/mL, p=0.800), but with no statistical signif-
icance (Fig. 3C). 
Relation of antidiuretic hormone to syndrome 
of inappropriate antidiuretic hormone secretion 
and cytokines
Plasma ADH levels (normal, <6.7 pg/mL) were measured 
in 7 KD patients with hyponatremia. Four patients with SI-
ADH had higher plasma ADH levels compared with 3 pa-
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Fig. 2. Correlations between serum sodium (Na) and (A) C-reactive protein (CRP), (B) N-terminal pro-brain natriuretic peptide (NT-proBNP), 
and (C) triiodothyronine (T3) in 50 patients with acute Kawasaki disease.
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tients without SIADH (17.0±8.2 pg/mL vs. 6.8±0.1 pg/mL, 
p=0.095). Plasma ADH concentrations positively correlated 
with serum levels of IL-6 (r=0.57, p=0.180) (Fig. 4A) and IL-
1β (r=0.64, p=0.119) (Fig. 4B). However, this correlations were 
not statistically significant. 
Contributing factors to hyponatremia in Kawasaki 
disease 
To detect the contributing factors to hyponatremia, five 
laboratory variables (% neutrophils, CRP, NT-proBNP, T3, 
and albumin) selected by the Mann-Whitney test plus two 
cytokines (IL-6 and IL-1β) were subjected to multivariate 
logistic regression analysis. No factors, however, were identi-
fied as independent contributors to hyponatremia in KD. 
Discussion
In the acute phase of the illness before IVIG infusion, hy-
ponatremia occurred in 13 of 50 KD patients (26%) and SI-
ADH was detected in 6 patients who comprised 46% of hy-
ponatremic patients. The incidence of hyponatremia in this 
study was lower than those (43.3% to 54.5%) reported by oth-
ers.
1)4)13) As serum Na levels were ≥125 mEq/L, no symptom-
atic hyponatremia occurred. Without specific management, 
hyponatremia normalized in almost all cases. Hyponatremia 
and SIADH also developed in the subacute phase after IVIG 
infusion. However, such occurrences are usually due to ex-
trinsic factors such as fluid therapy. 
The clinical significance of hyponatremia in KD was inves-
tigated. The patients with hyponatremia had higher % neu-
trophils, CRP, and NT-proBNP levels, and lower T3 and al-
bumin levels, indicating that hyponatremia occurs in patients 
exhibiting severe inflammation. Regarding T3 in KD, we 
have previously demonstrated that low T3 occurs in KD pa-
tients with higher CRP and NT-proBNP during the acute 
phase,
16) suggesting that T3 also may be useful in monitor-
ing the degree of inflammation together with CRP and NT-
proBNP.
17)18) Low albumin level has been recognized as a pre-
dictor of more severe KD with a higher risk of sequelae.
19) The 
finding of hyponatremia being associated with severe inflam-
mation is in close agreement with other studies.
4)13) With re-
gard to fever duration, there was no difference between pa-
tients with and without hyponatremia. This finding is in-
consistent with other studies reporting a longer duration of 
fever in patients with hyponatremia.
4)13) This difference could 
be attributed to hyponatremic patients with severe manifes-
tations presenting to hospitals earlier than patients without 
mild hyponatremia. In fact, the time elapsed from the disease 
onset to initial treatment was approximately one day shorter 
in patients with hyponatremia than in those without. Consid-
ering the relationship between hyponatremia and IVIG-re-
sistance, IVIG-resistance might occur more frequently in pa-
tients with hyponatremia, and hyponatremia might occur 
more commonly in patients with IVIG-resistance. Thus, hypon-
atremia and IVIG-resistance may have a mutual relationship 
and hyponatremia may serve as a predictor of IVIG-resistance 
as described previously.
20) In contrast, there was no correlation 
between hyponatremia and CALs in this study, which was in 
contrast to the results of other reports.
4)13) This difference was 
probably due to the small number of patients who had CALs in 
our study. Contrary to hyponatremia, the presence of SIADH 
was not associated with severe inflammation or IVIG-resistance. 
Several theories have been put forward as etiologies of hy-
ponatremia: hyponatremic dehydration, ingestion of hypoos-
molar fluid relative to excessive fluid loss,
1) SIADH,
1)3) and 
renal salt wasting.
13)21) Recently, as it has been recognized that 
ADH secretion may be activated by IL-6 and IL-1β,
9)10) in-
volvement of these cytokines was focused on as a pathogen-
esis of hyponatremia due to SIADH. Mastorakos et al.
9) have 
demonstrated increased ADH levels after IL-6 injection to 
cancer patients, indicative of stimulation of ADH secretion 
from magnocellular neurons by IL-6. Ohta and Ito
10) have 
reported 4 cases of hyponatremia due to SIADH associated 
with inflammation. Hyponatremia occurred when the pa-
tients had fever and high CRP levels. Simultaneously, IL-6 
and ADH levels were elevated with a significant correlation 
Fig. 4. Correlation of antidiuretic hormone (ADH) with serum levels of (A) interleukin (IL)-6 and (B) IL-1β in 7 Kawasaki disease patients with 
hyponatremia.
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between them. They also demonstrated in animal studies that 
intravenous administration of IL-1β increases ADH, atrial 
natriuretic peptide, adrenocorticotropic hormone, and uri-
nary Na excretion. As one of the main endocrine inflamma-
tory cytokines IL-6 is involved in the de novo production of 
acute phase proteins by hepatocytes, causes fever in response 
to tissue injury, and plays a central role in endothelial dam-
age in KD.
5) Also, IL-1β acts as a mediator of endothelial 
damage in KD.
22) Therefore, it is conceivable that these cyto-
kines may be involved in the pathogenic mechanisms of hy-
ponatremia and SIADH associated with KD.
We confirmed increased IL-6 and IL-1β levels during the 
acute phase of KD as reported in previous studies
5-8) and that 
KD patients with hyponatremia have higher levels of these 
cytokines compared with those without hyponatremia. In 
patients with SIADH, these cytokines and ADH levels might 
be higher than in those without. In addition, there was a ten-
dency of positive correlation between cytokines and ADH. 
These findings indicate that increased levels of serum IL-6 
and IL-1β in acute KD may activate ADH secretion, leading to 
SIADH and hyponatremia. 
With regard to the pathogenesis of hyponatremia in KD, 
several mechanisms may be suggested. KD is a systemic vas-
culitis and increased microvascular permeability is an initial 
step of the disease, causing hypoalbuminemia and noncar-
diogenic edema.
23) Vascular leakage induces decreased intra-
vascular volume and then activation of baroreceptors, leading 
to increased ADH secretion and hyponatremia.
24) This is an 
appropriate pathophysiological response to restore extracel-
lular fluid volume at the expense of hypoosmolarity. Hypo-
natremia also occurs as a result of ADH secretion that is in-
appropriate to both osmotic and fluid stimuli. Hyponatremia 
may result from increased natriuresis by IL-1β
10) and natri-
uretic peptide activity,
25)26) or from renal salt wasting due to 
either renal involvement
13)27) or a reduction in renal Na ab-
sorption.
21) It may also be caused by dilution of extracellular 
fluid due to impaired free water excretion, frequently occur-
ring during fever and severe infections.
28) The precise mech-
anisms for hyponatremia and SIADH in KD are not fully un-
derstood, but several factors could be active in the same 
patient. 
The study has several limitations. First, as a prospective 
study, it was difficult to enroll a large patient population 
during a short study period. Because of the small number of 
subjects in each group, no statistical differences between 
groups existed with respect to incidence of CALs, cytokines 
and ADH levels, nor did ADH statistically correlate with cy-
tokine levels. Secondly, because there were no KD patients 
who had CALs >5 mm in diameter, we were not able to inves-
tigate serum Na levels in patients with more severe coronary 
complications. Finally, although the results suggest that se-
rum IL-6 and IL-1β play a key role in the pathogenesis of hy-
ponatremia due to SIADH, these cytokines actually did not 
prove to be independent determinants of hyponatremia. This 
may have been partly due to the fact that hyponatremia sec-
ondary to cytokine-mediated ADH secretion occurred in only 
46% of all cases.
Despite these limitations, this study indicates that hypo-
natremia in KD occurs in patients exhibiting severe inflam-
mation. Hyponatremia may serve as a predictor of IVIG-re-
sistance. As a possible pathogenesis model, we suggest that 
increased IL-6 and IL-1β levels during the acute phase of KD 
may activate ADH secretion, leading to SIADH and hypona-
tremia. Larger studies are needed to clarify the pathogenic role 
of IL-6 and IL-1β on hyponatremia and SIADH in KD patients.
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